Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, with or Without Atrial Dysfunction and/or Dilated Cardiomyopathy (CPVT1)

儿茶酚胺多形性室性心动过速1型，伴或不伴功能障碍和/或扩张性心肌病(来自ICD-11)

别称:

Catecholaminergic Polymorphic Ventricular Tachycardia 1

Ventricular Tachycardia, Catecholaminergic Polymorphic, 1

Arrhythmogenic Right Ventricular Dysplasia 2

Ventricular Tachycardia, Stress-Induced Polymorphic

Stress-Induced Polymorphic Ventricular Tachycardia

Paroxysmal Ventricular Fibrillation

Bidirectional Tachycardia

Cpvt1

Vtsip

Tachycardia, Ventricular, Catecholaminergic Polymorphic, Type 1

Catecholaminergic Polymorphic Ventricular Tachycardia Type 1

Ventricular Tachycardia Catecholaminergic Polymorphic 1

Dysplasia, Arrhythmogenic Right Ventricular, Type 2

Malignant Paroxysmal Ventricular Tachycardia

Double Tachycardia Induced by Catecholamines

Paroxysmal Familial Ventricular Fibrillation

Multifocal Ventricular Premature Beats

Multifocal Premature Ventricular Beats

Syncopal Paroxysmal Tachycardia

Syncopal Tachyarythmia

Multifocal Pvcs

Cvpt1

加入收藏

基础信息

疾病表征

基因 & 突变

靶点药物

疾病模型

文献报道

心室心动过速，儿茶酚胺多形性，1型，伴有或不伴有心房功能障碍和/或扩张型心肌病，也称为儿茶酚胺多形性心室心动过速1型，与特发性室颤、非布加达类型和心脏ryanodine受体钙释放缺陷综合征引起的室性心律失常有关，症状包括癫痫发作和晕厥。与心室心动过速，儿茶酚胺多形性，1型，伴有或不伴有心房功能障碍和/或扩张型心肌病有关的重要基因是RYR2（ryanodine受体2），其相关通路/超级通路包括无机离子/氨基酸/寡肽的运输和DREAM抑制和二氢吗啡肽表达。钙、膳食和钙在该疾病的背景下被提及。相关组织包括心脏和房室结，相关表型是双向室性心动过速和晕厥。

查看原文参与反馈